CMPX
Price
$5.88
Change
-$0.16 (-2.65%)
Updated
Jan 15, 11:19 AM (EDT)
Capitalization
1.07B
43 days until earnings call
Intraday BUY SELL Signals
ORIC
Price
$11.40
Change
+$0.15 (+1.33%)
Updated
Jan 15, 11:57 AM (EDT)
Capitalization
1.1B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CMPX vs ORIC

Header iconCMPX vs ORIC Comparison
Open Charts CMPX vs ORICBanner chart's image
Compass Therapeutics
Price$5.88
Change-$0.16 (-2.65%)
Volume$3.3K
Capitalization1.07B
Oric Pharmaceuticals
Price$11.40
Change+$0.15 (+1.33%)
Volume$2.59K
Capitalization1.1B
CMPX vs ORIC Comparison Chart in %
CMPX
Daily Signal:
Gain/Loss:
ORIC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CMPX vs. ORIC commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Hold and ORIC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CMPX: $6.04 vs. ORIC: $11.25)
Brand notoriety: CMPX and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 293% vs. ORIC: 341%
Market capitalization -- CMPX: $1.07B vs. ORIC: $1.1B
CMPX [@Biotechnology] is valued at $1.07B. ORIC’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, ORIC is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 3 TA indicator(s) are bullish while ORIC’s TA Score has 4 bullish TA indicator(s).

  • CMPX’s TA Score: 3 bullish, 4 bearish.
  • ORIC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CMPX and ORIC are a bad buy in the short-term.

Price Growth

CMPX (@Biotechnology) experienced а +10.83% price change this week, while ORIC (@Biotechnology) price change was +29.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CMPX is expected to report earnings on Feb 27, 2026.

ORIC is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($1.1B) and CMPX($1.07B) have the same market capitalization . ORIC YTD gains are higher at: 37.531 vs. CMPX (12.477). CMPX has higher annual earnings (EBITDA): -69.96M vs. ORIC (-146.82M). ORIC has more cash in the bank: 287M vs. CMPX (220M). ORIC has less debt than CMPX: ORIC (3.3M) vs CMPX (9.87M). CMPX (0) and ORIC (0) have equivalent revenues.
CMPXORICCMPX / ORIC
Capitalization1.07B1.1B98%
EBITDA-69.96M-146.82M48%
Gain YTD12.47737.53133%
P/E RatioN/AN/A-
Revenue00-
Total Cash220M287M77%
Total Debt9.87M3.3M299%
TECHNICAL ANALYSIS
Technical Analysis
CMPXORIC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CMPX
Daily Signal:
Gain/Loss:
ORIC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMTYX10.540.05
+0.48%
AB All Market Real Return Advisor
FSEPX15.42N/A
N/A
Fidelity Advisor Sustainable U.S. Eq M
FVLKX14.59N/A
N/A
Fidelity Value K
BGIKX13.85-0.03
-0.22%
Baillie Gifford International Alpha K
BGFRX11.06-0.11
-0.98%
William Blair Growth R6

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
+8.24%
VCYT - CMPX
37%
Loosely correlated
-1.39%
ORIC - CMPX
35%
Loosely correlated
+10.95%
ARVN - CMPX
33%
Loosely correlated
-0.73%
EWTX - CMPX
32%
Poorly correlated
+12.91%
INSM - CMPX
32%
Poorly correlated
-0.16%
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with NRIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+10.95%
NRIX - ORIC
45%
Loosely correlated
+0.58%
ERAS - ORIC
45%
Loosely correlated
+10.73%
NUVL - ORIC
44%
Loosely correlated
+6.59%
RCUS - ORIC
43%
Loosely correlated
+8.00%
IDYA - ORIC
43%
Loosely correlated
+5.53%
More